BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8937391)

  • 21. Epidemiology of genital herpes simplex virus infection in developed countries.
    Malkin JE
    Herpes; 2004 Apr; 11 Suppl 1():2A-23A. PubMed ID: 15115626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers.
    McFarland W; Gwanzura L; Bassett MT; Machekano R; Latif AS; Ley C; Parsonnet J; Burke RL; Katzenstein D
    J Infect Dis; 1999 Nov; 180(5):1459-65. PubMed ID: 10515804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of herpes simplex virus 2 among Hispanics in the USA: National Health and Nutrition Examination Survey, 2007-2008.
    Molina M; Romaguera RA; Valentine J; Tao G
    Int J STD AIDS; 2011 Jul; 22(7):387-90. PubMed ID: 21729957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania.
    Obasi A; Mosha F; Quigley M; Sekirassa Z; Gibbs T; Munguti K; Todd J; Grosskurth H; Mayaud P; Changalucha J; Brown D; Mabey D; Hayes R
    J Infect Dis; 1999 Jan; 179(1):16-24. PubMed ID: 9841817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethnic variation in type of genital herpes simplex virus infection in a South London genitourinary medicine clinic.
    Strutt M; Bailey J; Tenant-Flowers M; Graham D; Zuckerman M
    J Med Virol; 2003 Jan; 69(1):108-10. PubMed ID: 12436485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreasing prevalence of herpes simplex virus-2 antibodies in selected groups of women in Sweden.
    Berntsson M; Tunbäck P; Ellström A; Krantz I; Löwhagen GB
    Acta Derm Venereol; 2009 Nov; 89(6):623-6. PubMed ID: 19997695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A seroprevalence study of herpes virus type 2 infection in Israeli women: implications for routine screening.
    Isacsohn M; Bar On E; Yaeger Y; Smetana Z; Weiner D; Slater PE
    Isr J Med Sci; 1994; 30(5-6):379-83. PubMed ID: 8034487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sexual and demographic determinants for herpes simplex virus type 2 among fishermen along Lake Victoria, Kenya.
    O Ng'ayo M; Bukusi E; A Morrow R; Rowhani-Rahbar A; A Obare B; Friedrich D; Holmes KK
    Sex Transm Infect; 2008 Apr; 84(2):140-2. PubMed ID: 18096647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of herpes simplex virus type 1 and type 2 among the Indigenous population of Cape York, Far North Queensland, Australia.
    Brazzale AG; Russell DB; Cunningham AL; Taylor J; McBride WJ
    Sex Health; 2010 Dec; 7(4):453-9. PubMed ID: 21062586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of specific herpes simplex virus-2 antibodies and associated factors in women of a rural town of Colombia.
    Sierra CA; Bedoya AM; Paris S; Baena A; Gaviria AM; Rojas CA; Arbelaez MP; Sanchez GI
    Trans R Soc Trop Med Hyg; 2011 Apr; 105(4):232-8. PubMed ID: 21353272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010.
    Bradley H; Markowitz LE; Gibson T; McQuillan GM
    J Infect Dis; 2014 Feb; 209(3):325-33. PubMed ID: 24136792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acceptance and outcome of herpes simplex virus type 2 antibody testing in patients attending an STD clinic--recognized and unrecognized infections.
    Löwhagen GB; Berntsson M; Bonde E; Tunbäck P; Krantz I
    Acta Derm Venereol; 2005; 85(3):248-52. PubMed ID: 16040412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors of herpes simplex virus type 2 among STD clinic attenders in Delhi, India.
    Kaur R; Mittal N; Bhalla P; Reddy BN; Baveja UK
    J Commun Dis; 2006 Dec; 38(4):339-43. PubMed ID: 17913210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of antibodies to herpes simplex virus 2 among homosexual men either positive or negative for human immunodeficiency viruses in Slovakia.
    Bystrická M; Gasparovicová L; Staneková D; Mokrás M; Soláriková L; Russ G
    Acta Virol; 2000; 44(3):163-7. PubMed ID: 11155359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpes simplex virus type 2 prevalence of epidemic proportions in rural Zimbabwean women: association with other sexually transmitted infections.
    Kjetland EF; Gwanzura L; Ndhlovu PD; Mduluza T; Gomo E; Mason PR; Midzi N; Friis H; Gundersen SG
    Arch Gynecol Obstet; 2005 Jun; 272(1):67-73. PubMed ID: 15647913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and risk factors for herpes simplex virus type 2 infection among pregnant women in Israel.
    Dan M; Sadan O; Glezerman M; Raveh D; Samra Z
    Sex Transm Dis; 2003 Nov; 30(11):835-8. PubMed ID: 14603091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic.
    Austin H; Macaluso M; Nahmias A; Lee FK; Kelaghan J; Fleenor M; Hook EW
    Sex Transm Dis; 1999 Jul; 26(6):329-34. PubMed ID: 10417020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type-specific herpes simplex virus-1 and herpes simplex virus-2 seroprevalence in Romania: comparison of prevalence and risk factors in women and men.
    Arama V; Cercel AS; Vladareanu R; Mihai C; Mihailescu R; Rankin J; Goschin S; Filipescu A; Rafila A; Arama S; Hristea A; Malkin JE; Pimenta JM; Smith JS
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e25-31. PubMed ID: 20106695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.
    Görander S; Mbwana J; Lyamuya E; Lagergård T; Liljeqvist JA
    Clin Vaccine Immunol; 2006 Jun; 13(6):633-9. PubMed ID: 16760320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herpes Simplex virus type 2 seroprevalence and risk factors among adolescents and youth with HIV-1 in Northern, Tanzania.
    Madebe R; Kiwelu I; Ndaro A; Francis F; Baraka V; Theilgaard Z; Katzenstein T
    J Infect Dev Ctries; 2020 Apr; 14(4):398-403. PubMed ID: 32379718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.